首(shǒu)頁 > 產(chǎn)品中心 > 科研抗體 > 標記一(yī)抗
產(chǎn)品中(zhōng)心(xīn)
標記一抗
FITC標(biāo)記(jì)的(dí)ATP酶H+轉運溶酶體(tǐ)輔助蛋白(bái)2抗(kàng)體(tǐ)
文字：[大(dà)][中(zhōng)][小(xiǎo)]
2017-5-3 瀏(liú)覽(lǎn)次數：1482
英(yīng)文(wén)名(míng)稱(chēng)Anti-ATP6IP2/FITC
中文(wén)名稱(chēng):FITC標記(jì)的ATP酶(méi)H+轉運(yùn)溶酶體輔(fǔ)助蛋白2抗(kàng)體
別 名(míng)APT6M8 9; ATP6AP2; ATP6M8-9; ATPase H(+)-transporting lysosomal accessory protein 2; ATPase H(+)-transporting lysosomal-interacting protein 2; ATPase H+ transporting lysosomal accessory protein 2; ATPase H+ transporting lysosomal interacting protein 2; ATPase H+ transporting lysosomal vacuolar proton pump membrane sector associated protein M8 9; ATPase membrane sector associated protein M8 9; CAPER; ELDF10; Embryonic liver differentiation factor 10; ER localized type I transmembrane adaptor; ER-localized type I transmembrane adaptor; HT028; M8 9; MRXE; N14F; Renin receptor; Renin/prorenin receptor; RENR_HUMAN; V ATPase M8 9 subunit; V ATPase M8.9 subunit; V-ATPase M8.9 subunit; Vacuolar ATP synthase membrane sector associated protein M8 9; Vacuolar ATP synthase membrane sector-associated protein M8-9; vacuolar proton ATP synthase membrane sector associated protein M8 9; XMRE.
規格(gé):100ul
說(shuō) 明 書100ul
研究領域(yù)細(xì)胞(bāo)生物 通(tōng)道蛋白 轉運蛋白 細(xì)胞表麵分子
抗體(tǐ)來源(yuán)Rabbit
克(kè)隆類型Polyclonal
交叉(chā)反(fǎn)應 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit,
產(chǎn)品應用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分(fēn) 子(zǐ) 量(liáng)37kDa
細胞(bāo)定位細(xì)胞(bāo)膜
性 狀(zhuàng)Lyophilized or Liquid
濃(nóng) 度(dù)1mg/ml
免(miǎn) 疫 原KLH conjugated synthetic peptide derived from human ATP6IP2
亞 型(xíng)IgG
純(chún)化(huà)方法(fǎ)affinity purified by Protein A
儲(chǔ) 存(cún) 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保(bǎo)存(cún)條件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
產品介(jiè)紹(shào)background:
This gene encodes a protein that is associated with adenosine triphosphatases (ATPases). Proton-translocating ATPases have fundamental roles in energy conservation, secondary active transport, acidification of intracellular compartments, and cellular pH homeostasis. There are three classes of ATPases- F, P, and V. The vacuolar (V-type) ATPases have a transmembrane proton-conducting sector and an extramembrane catalytic sector. The encoded protein has been found associated with the transmembrane sector of the V-type ATPases. [provided by RefSeq, Jul 2008].
Function:
Functions as a renin and prorenin cellular receptor. May mediate renin-dependent cellular responses by activating ERK1 and ERK2. By increasing the catalytic efficiency of renin in AGT/angiotensinogen conversion to angiotensin I, it may also play a role in the renin-angiotensin system (RAS).
Subunit:
Interacts with renin and the vacuolar proton-ATPase.
Subcellular Location:
Membrane; Single-pass type I membrane protein (Potential).
Tissue Specificity:
Expressed in brain, heart, placenta, liver, kidney and pancreas. Barely detectable in lung and skeletal muscles. In the kidney cortex it is restricted to the mesangium of glomeruli. In the coronary and kidney artery it is expressed in the subendothelium, associated to smooth muscles where it colocalizes with REN. Expressed in vascular structures and by syncytiotrophoblast cells in the mature fetal placenta.
Post-translational modifications:
Phosphorylated.
DISEASE:
Defects in ATP6AP2 are a cause of mental retardation X-linked with epilepsy (MRXE) [MIM:300423]. MRXE is a syndromic mental retardation. Patients manifest mild to moderate mental retardation associated with epilepsy, delays in motor milestones and speech acquisition in infancy.
中文(wén)名稱(chēng):FITC標記(jì)的ATP酶(méi)H+轉運(yùn)溶酶體輔(fǔ)助蛋白2抗(kàng)體
別 名(míng)APT6M8 9; ATP6AP2; ATP6M8-9; ATPase H(+)-transporting lysosomal accessory protein 2; ATPase H(+)-transporting lysosomal-interacting protein 2; ATPase H+ transporting lysosomal accessory protein 2; ATPase H+ transporting lysosomal interacting protein 2; ATPase H+ transporting lysosomal vacuolar proton pump membrane sector associated protein M8 9; ATPase membrane sector associated protein M8 9; CAPER; ELDF10; Embryonic liver differentiation factor 10; ER localized type I transmembrane adaptor; ER-localized type I transmembrane adaptor; HT028; M8 9; MRXE; N14F; Renin receptor; Renin/prorenin receptor; RENR_HUMAN; V ATPase M8 9 subunit; V ATPase M8.9 subunit; V-ATPase M8.9 subunit; Vacuolar ATP synthase membrane sector associated protein M8 9; Vacuolar ATP synthase membrane sector-associated protein M8-9; vacuolar proton ATP synthase membrane sector associated protein M8 9; XMRE.
詳細(xì)介紹(shào)：
規格(gé):100ul
說(shuō) 明 書100ul
研究領域(yù)細(xì)胞(bāo)生物 通(tōng)道蛋白 轉運蛋白 細(xì)胞表麵分子
抗體(tǐ)來源(yuán)Rabbit
克(kè)隆類型Polyclonal
交叉(chā)反(fǎn)應 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit,
產(chǎn)品應用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分(fēn) 子(zǐ) 量(liáng)37kDa
細胞(bāo)定位細(xì)胞(bāo)膜
性 狀(zhuàng)Lyophilized or Liquid
濃(nóng) 度(dù)1mg/ml
免(miǎn) 疫 原KLH conjugated synthetic peptide derived from human ATP6IP2
亞 型(xíng)IgG
純(chún)化(huà)方法(fǎ)affinity purified by Protein A
儲(chǔ) 存(cún) 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保(bǎo)存(cún)條件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
相關資料：
產品介(jiè)紹(shào)background:
This gene encodes a protein that is associated with adenosine triphosphatases (ATPases). Proton-translocating ATPases have fundamental roles in energy conservation, secondary active transport, acidification of intracellular compartments, and cellular pH homeostasis. There are three classes of ATPases- F, P, and V. The vacuolar (V-type) ATPases have a transmembrane proton-conducting sector and an extramembrane catalytic sector. The encoded protein has been found associated with the transmembrane sector of the V-type ATPases. [provided by RefSeq, Jul 2008].
Function:
Functions as a renin and prorenin cellular receptor. May mediate renin-dependent cellular responses by activating ERK1 and ERK2. By increasing the catalytic efficiency of renin in AGT/angiotensinogen conversion to angiotensin I, it may also play a role in the renin-angiotensin system (RAS).
Subunit:
Interacts with renin and the vacuolar proton-ATPase.
Subcellular Location:
Membrane; Single-pass type I membrane protein (Potential).
Tissue Specificity:
Expressed in brain, heart, placenta, liver, kidney and pancreas. Barely detectable in lung and skeletal muscles. In the kidney cortex it is restricted to the mesangium of glomeruli. In the coronary and kidney artery it is expressed in the subendothelium, associated to smooth muscles where it colocalizes with REN. Expressed in vascular structures and by syncytiotrophoblast cells in the mature fetal placenta.
Post-translational modifications:
Phosphorylated.
DISEASE:
Defects in ATP6AP2 are a cause of mental retardation X-linked with epilepsy (MRXE) [MIM:300423]. MRXE is a syndromic mental retardation. Patients manifest mild to moderate mental retardation associated with epilepsy, delays in motor milestones and speech acquisition in infancy.
